Key result
Angiotensin 1-9 cuts cardiomyocyte autophagic flux ~45% via an AT2R and Akt-dependent pathway.
Why the study?
Angiotensin-(1-9) has an anti-hypertrophic effect in cardiomyocytes through an unknown mechanism, prompting investigation into its effect on cardiomyocyte autophagy.
p-value: p=<0.01
Angiotensin-(1-9) suppresses both basal and Angiotensin II-induced autophagy in cardiomyocytes via the AT2R/Akt/ERK pathway, offering a potential molecular mechanism for its cardioprotective effects.
Angiotensin-(1-9) effects on cardiomyocyte autophagy should not yet change practice; leaves open its role in human cardiac remodeling.
Background The renin-angiotensin system (RAS) plays a pivotal role in regulating blood volume, systemic vascular resistance, and electrolyte balance, serving as a key component of cardiovascular health. Recent findings highlight the role of angiotensin II (Ang II) in inducing autophagy through angiotensin II receptor type 1 (AT1R). Autophagy, a process of self-degradation and turnover of cellular components, is a homeostatic response that eliminates superfluous materials. Abnormal autophagy promotes cardiomyocyte loss and is critical in hypertrophy and heart failure progression. The RAS's non-canonical axis, which includes the angiotensin 1-9 peptide [Ang-(1-9)], has an anti-hypertrophic effect in cardiomyocytes via an unknown mechanism . In the present study, we aimed to elucidate the effect of Ang-(1-9) on cardiomyocyte autophagy. Methods We i solated and cultured neonatal ventricular cardiomyocytes and then co- treated them with Ang-(1-9) in the presence of chloroquine (CQ), Ang-II, and chemical inhibitors of different signaling pathways. After treatment, total RNA and protein extracts were obtained to analyze the abundance of different autophagy markers. Likewise, cells were fixed, and autophagy was analyzed through epifluorescence microscopy. Results Our findings show that CQ leads to a reduction in autophagy markers, such as microtubule-associated protein 1 light chain 3-II (LC3-II) and total LC3, suggesting Ang-(1-9)'s regulatory role in basal autophagy levels. Furthermore, Ang-(1-9) opposes Ang-II-induced autophagy and induces the phosphorylation of the S234 residue of Beclin-1 (BCN1) via an angiotensin II receptor type 2 (AT2R)/Akt-dependent pathway. Conclusions This reduction of Ang-II-induced autophagy by Ang-(1-9) unveils a novel aspect of its action, potentially contributing to its cardioprotective effects.
No takes yet. Share an insight, caveat, or question.
Bustamante et al. (2025) studied Cardiomyocyte autophagy and hypertrophy (preclinical model). Angiotensin-(1-9) vs. Untreated control, Angiotensin II alone, or Chloroquine alone was evaluated on Abundance of autophagy markers (LC3-II and p62) (p=<0.01). Angiotensin-(1-9) reduced basal autophagic flux by 45% and counteracted Angiotensin II-induced autophagy in cultured cardiomyocytes via an AT2R/Akt-dependent pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: